Page URL: https://www.bionews.org.uk/page_90125

Genetic risk factor for Parkinson's disease identified

14 August 2006
Appeared in BioNews 371

US researchers have identified a genetic risk factor that they say could account for three per cent of the cause of Parkinson's disease (PD). The team, based at the Mayo Clinic in Rochester, Minnesota, has shown that people who inherit a DNA change that increases production of a protein called alpha synuclein have a 50 per cent greater risk of developing the condition. The scientists, who published their findings in the Journal of the American Medical Association, say the study provides evidence that common genetic variants contribute to PD.

People with PD are affected by tremors, stiff muscles and slow movements, caused by a gradual loss of nerve cells in an area of the brain controlling movement. It is not known what triggers this loss, but PD is not normally inherited. However, the illness does occasionally run in families, where the symptoms often appear at a younger age than in non-inherited cases. Researchers think that there are around ten different types of inherited PD, each caused by mutations in different gene. One of these is the alpha synuclein gene (SNCA).

In contrast, most cases of non-inherited PD are thought to be caused by a combination of genetic and non-genetic factors. In the latest study, the researchers analysed genetic and clinical information from 2,692 PD patients and 2,652 healthy controls. They focussed on a particular DNA variation, which, in its longer form, causes over-production of the alpha synuclein protein. The scientists discovered that people with this longer version had a 1.5 times greater risk of developing PD.

Team leader Dr Demetrius Maraganore said that while previous, smaller studies had linked SNCA variations to PD susceptibility, the new research provided 'much-needed evidence' that they contribute to the disease risk in people worldwide. He also said that 'our findings support the development of therapies that reduce alpha-synuclein gene expression. Such therapies have the potential to prevent or delay the onset of Parkinson's disease or to halt or slow its progression'. The scientists stress that further research is needed to confirm the findings, and to investigate how SNCA interacts with other genetic and non-genetic risk factors for PD.

SOURCES & REFERENCES
Hunting Down Parkinson's Risks
Ivanhoe.com |  9 August 2006
Strong evidence of a genetic risk factor for Parkinson's disease
EurekaAlert |  8 August 2006
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
25 March 2013 - by Helen Brooks 
An experimental approach to treating Parkinson's disease may need to be reconsidered following evidence suggesting that it may make patients worse...
26 January 2006 - by BioNews 
US researchers have found that many cases of Parkinson's disease (PD) in certain ethnic groups could be triggered by a single faulty gene. In two separate studies, the scientists discovered that some patients with an Ashkenazi Jewish or Arabic background have a mutated version of the LRRK2 gene. The findings...
21 January 2005 - by BioNews 
Mutations in a gene involved in familial Parkinson's disease (PD) could be responsible for one in 25 cases of PD worldwide, new research shows. Three studies published in the Lancet have pinpointed a mutation in the LRRK2 gene that could cause around five per cent of inherited cases of PD...
19 April 2004 - by BioNews 
The identification of a gene involved in a rare hereditary form of Parkinson's disease could lead to new treatments for this incurable brain disorder, UK scientists say. Families affected by a severe, inherited form of the illness have an altered version of a gene called PINK1 (PTEN-induced kinase 1), researchers...
HAVE YOUR SAY
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.